![Trastuzumab Emtansine: Mechanisms of Action and Resistance, Clinical Progress, and Beyond: Trends in Cancer Trastuzumab Emtansine: Mechanisms of Action and Resistance, Clinical Progress, and Beyond: Trends in Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/7a1926a2-bcf9-46c5-a600-9e1406c31400/gr1_lrg.jpg)
Trastuzumab Emtansine: Mechanisms of Action and Resistance, Clinical Progress, and Beyond: Trends in Cancer
![Cancers | Free Full-Text | The Changing Paradigm for the Treatment of HER2-Positive Breast Cancer | HTML Cancers | Free Full-Text | The Changing Paradigm for the Treatment of HER2-Positive Breast Cancer | HTML](https://www.mdpi.com/cancers/cancers-12-02081/article_deploy/html/images/cancers-12-02081-g001.png)
Cancers | Free Full-Text | The Changing Paradigm for the Treatment of HER2-Positive Breast Cancer | HTML
![Structure of trastuzumab emtansine and mechanisms of action. Notes: On... | Download Scientific Diagram Structure of trastuzumab emtansine and mechanisms of action. Notes: On... | Download Scientific Diagram](https://www.researchgate.net/publication/267932500/figure/fig1/AS:601626331058214@1520450303996/Structure-of-trastuzumab-emtansine-and-mechanisms-of-action-Notes-On-binding-of.png)
Structure of trastuzumab emtansine and mechanisms of action. Notes: On... | Download Scientific Diagram
![A comparative phase III clinical study to evaluate efficacy and safety of TrastuRel™ (biosimilar trastuzumab) and innovator trastuzumab in patients with metastatic human epidermal growth factor receptor 2 (HER2)-overexpressing breast cancer A comparative phase III clinical study to evaluate efficacy and safety of TrastuRel™ (biosimilar trastuzumab) and innovator trastuzumab in patients with metastatic human epidermal growth factor receptor 2 (HER2)-overexpressing breast cancer](https://indianjcancer.com/articles/2017/54/4/images/IndianJournalofCancer_2017_54_4_664_237899_f1.jpg)
A comparative phase III clinical study to evaluate efficacy and safety of TrastuRel™ (biosimilar trastuzumab) and innovator trastuzumab in patients with metastatic human epidermal growth factor receptor 2 (HER2)-overexpressing breast cancer
![Trastuzumab: mechanism of action, resistance and future perspectives in HER2-overexpressing breast cancer - Annals of Oncology Trastuzumab: mechanism of action, resistance and future perspectives in HER2-overexpressing breast cancer - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/3939bb25-73dd-487a-8490-1dae0e8d6902/gr1.jpg)